227 Discussion REFERENCES 1. Nieder C, Spanne O, Mehta MP, et al. Presentation, patterns of care, and survival in patients with brain metastases: What has changed in the last 20 years? Cancer 2011; 117: 2505–2512. 2. Lanier CM, Hughes R, Ahmed T, et al. Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries. Neurooncol Pract 2019; 6: 402–409. 3. Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep 2012; 14: 48–54. 4. Jin J, Gao Y, Zhang J, et al. Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer. BMC Cancer; 18. Epub ahead of print 19 April 2018. DOI: 10.1186/s12885-018-4371-0. 5. Karlsson AT, Hjermstad MJ, Omdahl T, et al. Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer. Acta Oncol (Madr) 2021; 60: 1054–1060. 6. Lin X, DeAngelis LM. Treatment of brain metastases. Journal of Clinical Oncology 2015; 33: 3475–3484. 7. Alvarez-Breckenridge C, Remon J, Piña Y, et al. Emerging Systemic Treatment Perspectives on Brain Metastases: Moving Toward a Better Outlook for Patients. American Society of Clinical Oncology Educational Book 2022; 147–165. 8. Rick JW, Shahin M, Chandra A, et al. Systemic therapy for brain metastases. Crit Rev Oncol Hematol 2019; 142: 44–50. 9. Hodgson KD, Hutchinson AD, Wilson CJ, et al. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev 2013; 39: 297–304. 10. Joly F, Castel H, Tron L, et al. Potential effect of immunotherapy agents on cognitive function in cancer patients. J Natl Cancer Inst 2020; 112: 123–127. 11. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012; 12: 267–275. 12. Schagen SB, Tsvetkov AS, Compter A, et al. Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach? Nat Rev Neurol 2022; 18: 173–185. 13. de Ruiter MB, Deardorff RL, Blommaert J, et al. Brain gray matter reduction and premature brain aging after breast cancer chemotherapy: a longitudinal multicenter data pooling analysis. Brain Imaging Behav. Epub ahead of print 2023. DOI: 10.1007/s11682-023-00781-7. 14. Huisman SI, van der Boog ATJ, Cialdella F, et al. Quantifying the post-radiation accelerated brain aging rate in glioma patients with deep learning. Radiotherapy and Oncology 2022; 175: 18–25. 15. Peters S, Bexelius C, Munk V, et al. The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer. Cancer Treat Rev 2016; 45: 139–162. 16. Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol 2017; 19: 1511–1521. 9
RkJQdWJsaXNoZXIy MTk4NDMw